Insulin aspart, recombinant Subcutaneous and TheraCys
Determining the interaction of Insulin aspart, recombinant Subcutaneous and TheraCys and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: bcg
Brand name: TheraCys, Tice BCG, Tice BCG Live, Tice BCG Vaccine, Theracys 3, BCG vaccine
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Theraflu (pseudoephedrine) Cold & Cough
- Insulin aspart, recombinant Subcutaneous-Theraflu (pseudoephedrine) Daytime Severe Cold
- Insulin aspart, recombinant Subcutaneous-Theraflu Cold and Cough
- Insulin aspart, recombinant Subcutaneous-Theraflu Cold and Sore Throat
- Insulin aspart, recombinant Subcutaneous-Theraflu Cold/Cough Nighttime
- Insulin aspart, recombinant Subcutaneous-Theraflu Daytime Severe Cold
- TheraCys-Insulin degludec
- TheraCys-Insulin Degludec (U-100) Prefilled Pens
- TheraCys-Insulin Degludec (U-100) Vials
- TheraCys-Insulin Degludec (U-200) Prefilled Pens
- TheraCys-Insulin degludec and liraglutide
- TheraCys-Insulin degludec and liraglutide Subcutaneous